rev131
Small moleculeexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2005 (NCT00247520)
Timeline
Indications
Mechanism of action
- Histamine H1 receptorINHIBITOR
HRH1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- rev131
- rev131
- rev131
- rev131 protein, tick
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00353964 | Phase 2 | Jul 17, 2006 | Evolutec Group |
| NCT00247520 | Phase 1/Phase 2 (Phase 2) | May 1, 2005 | Evolutec Group |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Evolutec Group | For profit | 2 | 2 | 1 | 2005 |
1 organizations
Page 1 / 1